Market Outlook

By 2035, the U.S. Medical Robotics and Navigation Systems Market is expected to reach approximately USD 42.60 billion, expanding at a CAGR of 13.65% during the forecast period 2026–2035. The market was valued at approximately USD 11.85 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions.

The U.S. medical robotics and navigation systems industry has moved from a premium technology niche into a strategically important layer of modern procedural medicine. Robotic-assisted surgery, computer-assisted navigation, image-guided intervention, endoluminal robotics, orthopedic robotic execution, spine guidance, neurosurgical navigation, and robotic radiosurgery are increasingly embedded within high-value clinical service lines. The market is supported not only by capital-system installations but also by recurring instrument and accessory utilization, software upgrades, service contracts, procedure-specific disposables, digital planning tools, and increasingly AI-enabled workflow applications.

For market-sizing purposes, the addressable market includes medical robotic platforms, surgical navigation hardware and software, robotic instruments and accessories, navigation disposables, procedure-linked software, maintenance and service revenue, and specialized robotic intervention technologies. Conventional implants, standalone diagnostic imaging systems, standard surgical instruments, and unrelated operating-room equipment are excluded unless their revenue is specifically attributable to a robotics or navigation workflow. This definition is critical because orthopedic implants, imaging systems, and general surgical consumables can otherwise materially overstate the size of the robotics market.

The historical market expanded from approximately USD 6.62 billion in 2021 to USD 10.13 billion in 2024, reflecting normalization of elective procedures following the pandemic, higher utilization of existing robotic platforms, expansion of orthopedic and spine robotics, stronger robotic general-surgery adoption, and increasing recurring instrument and service revenue. The market reached approximately USD 11.85 billion in 2025, supported by a major upgrade cycle in soft-tissue robotics, continued robotic joint-replacement penetration, expansion of pulmonary robotic bronchoscopy, and wider deployment of navigation systems across spine, neurosurgery, ENT, orthopedic surgery, and complex interventions.

The forecast is intentionally weighted toward procedure utilization rather than system placements alone. By 2026, the market is expected to approach USD 13.47 billion, rising toward approximately USD 22.47 billion by 2030 and USD 42.60 billion by 2035. Revenue growth will increasingly come from procedures performed on installed platforms, recurring instruments, software and analytics, service contracts, system replacements, broader indications, ASC penetration, and migration from navigation-only workflows toward integrated robotic execution.

One of the strongest indicators of U.S. market maturity is the scale already achieved by Intuitive Surgical. In 2025, the company generated approximately USD 6.82 billion in U.S. revenue across systems, instruments and accessories, and services. Its U.S. da Vinci installed base reached approximately 6,364 systems, while roughly 2.01 million da Vinci procedures were performed in the U.S. during 2025, representing approximately 15% annual procedural growth. These figures demonstrate that medical robotics is already a substantial recurring procedural market rather than a capital-equipment market dependent primarily on new installations.

 

Introduction

According to the U.S. Medical Robotics and Navigation Systems Market Report, the industry is being shaped by convergence among robotic execution, surgical navigation, advanced imaging, procedure planning, AI-enabled guidance, connected operating-room infrastructure, and recurring procedural economics. The most valuable platforms no longer function simply as mechanical assistants. They increasingly support preoperative planning, intraoperative localization, instrument tracking, tissue manipulation, bone preparation, imaging integration, case documentation, data capture, and post-procedure performance analysis.

The United States remains the most commercially important medical robotics market because it combines high surgical volumes, sophisticated hospital infrastructure, specialist concentration, strong adoption of minimally invasive care, comparatively favorable access to medical technology, deep clinical-trial capabilities, and large public and private reimbursement pools. The country had approximately 61.2 million residents aged 65 years or older in 2024, representing about 18% of the population. Aging directly expands the pool of patients requiring joint replacement, prostate surgery, colorectal procedures, thoracic intervention, spine procedures, cancer surgery, and other interventions in which robotic and navigation technologies can provide workflow or precision advantages.

The addressable customer base is also extensive. The U.S. hospital system includes approximately 6,100 hospitals, more than 907,000 staffed beds, and over 35 million annual admissions. At the same time, roughly 6,000 Medicare-participating ambulatory surgery centers represent an increasingly important site of care. This combination creates two different robotics procurement environments. Large hospitals frequently prioritize multi-specialty capability, procedure growth, surgeon recruitment, data integration, and enterprise contracting, whereas ASCs emphasize smaller footprints, rapid room turnover, lower capital intensity, predictable disposables, and faster return on invested capital.

The market is clinically diversified. Soft-tissue robotics is heavily used across general surgery, urology, gynecology, colorectal surgery, thoracic surgery, and selected cardiac applications. Orthopedic robotics is increasingly integrated into total knee, partial knee, hip, shoulder, and emerging spine workflows. Navigation remains central to spine, cranial neurosurgery, ENT, orthopedic reconstruction, trauma, and image-guided intervention. Endoluminal robotic systems are expanding into lung biopsy and potentially other natural-orifice applications. Robotic radiosurgery adds another high-acuity segment in oncology and neurological treatment.

This diversity reduces dependence on a single specialty. It also makes competitive strategy more complex. Hospitals increasingly compare platforms on total procedural economics, clinical applicability, surgeon adoption, instrument availability, service uptime, integration with existing implants or imaging systems, data architecture, upgrade pathways, and whether a platform can generate sufficient incremental case volume to justify capital and operating costs.

 

Key Market Drivers: What’s Fueling the U.S. Medical Robotics and Navigation Systems Market Boom?

The first major driver is the continued shift toward minimally invasive and precision-guided intervention. U.S. providers increasingly seek surgical approaches capable of reducing incision size, improving visualization, standardizing critical procedural steps, and enabling clinicians to work within anatomically constrained spaces. Robotically assisted surgical systems are particularly attractive in procedures requiring fine dissection, suturing, tissue manipulation, stable visualization, complex reconstruction, or highly repeatable bone preparation.

A second driver is the expanding volume of age-related musculoskeletal procedures. The American Joint Replacement Registry has accumulated data covering more than 5 million hip and knee replacement procedures, illustrating the scale of the U.S. arthroplasty opportunity. Robotics is increasingly becoming a competitive differentiator in joint-replacement programs because hospitals and surgeons can combine digital planning, alignment analysis, intraoperative balancing, robotic bone preparation, and implant-placement workflows. The technology is also moving beyond high-volume tertiary hospitals into regional orthopedic hospitals and ASCs.

Stryker’s Mako ecosystem illustrates this scaling effect. More than 2.5 million Mako procedures had been performed globally through 2025, providing a large clinical and commercial installed base. Smith+Nephew reported more than 1,100 CORI systems installed worldwide by the end of 2025, and 36% of the company’s U.S. knee implants were being completed with CORI. Zimmer Biomet’s ROSA installed base was approaching 2,000 systems globally during 2025. These data indicate that orthopedic robotics is moving from early adoption into competitive platform standardization.

A third driver is the scale of soft-tissue surgery in the United States. In 2025 alone, approximately 2.04 million new cancer cases were expected nationally. Prostate cancer accounted for approximately 313,780 new cases, colorectal cancer for more than 154,000 cases, and lung cancer for more than 226,000 cases. These disease categories intersect directly with robotic prostatectomy, colorectal surgery, thoracic procedures, hysterectomy, oncologic resection, pulmonary biopsy, and other image-guided interventions.

General surgery is especially important because it provides a much larger procedure pool than oncology alone. Robotic cholecystectomy, inguinal and ventral hernia repair, appendectomy, bariatric procedures, colorectal surgery, and other abdominal procedures are increasing utilization of existing systems. Intuitive reported approximately 18% growth in U.S. da Vinci general-surgery procedures during 2025, demonstrating that benign procedures are becoming increasingly important to robotic platform economics.

A fourth driver is hospital capital procurement behavior. Robots are typically evaluated through multidisciplinary capital committees rather than purchased solely at the request of an individual surgeon. U.S. hospitals increasingly model utilization by specialty, contribution margin, surgeon recruitment, expected procedure migration, operating-room time, staffing requirements, disposables, service cost, and competitive positioning. A robot that can support multiple surgical departments or materially increase case capture has a stronger capital case than a narrowly utilized platform.

Reimbursement creates an important economic discipline. Robotic assistance generally does not create an automatic incremental Medicare payment simply because a robot is used. Hospitals therefore must economically justify robotics through clinical outcomes, procedural efficiency, downstream utilization, surgeon productivity, patient preference, market-share capture, or strategic service-line differentiation. This characteristic strongly favors systems capable of delivering high utilization rather than technologies dependent primarily on premium capital pricing.

A fifth driver is expansion into ambulatory surgery. CMS payment policies affect approximately 6,000 ASCs, and outpatient migration is becoming particularly important in orthopedics. Compact robotic and navigation systems with lower physical footprints, simplified registration, shorter setup cycles, and flexible commercial models are increasingly positioned for these facilities. Vendors are responding through handheld robotics, imageless navigation, smaller consoles, modular systems, leasing structures, placement agreements, and procedural pricing.

A sixth driver is the rapid improvement of AI, visualization, and intraoperative computing. Navigation systems are moving beyond static instrument tracking toward anatomy recognition, automated registration, surgical planning, digital templating, predictive alignment, intraoperative analytics, and eventually selected autonomous functions. As AI becomes embedded directly into procedural platforms, software could account for a larger portion of customer lifetime value even when the original capital system remains installed for many years.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. medical robotics and navigation systems market is increasingly focused on platform flexibility, smaller footprints, AI-assisted guidance, improved sensing, modular architectures, automation, and integration between hardware and procedure data. The competitive question is shifting from whether a manufacturer has a robot to whether its ecosystem can improve enough of the clinical workflow to justify long-term platform adoption.

Soft-tissue robotics is entering a more competitive phase. Intuitive continues to expand the da Vinci ecosystem through the da Vinci 5 upgrade cycle, single-port surgery, instrumentation, imaging, digital capabilities, and high procedure utilization. Its 2025 U.S. installed base exceeded 6,300 da Vinci systems, creating a substantial network effect around training, clinical familiarity, service infrastructure, and recurring instrumentation.

Competitive intensity increased materially when Medtronic received U.S. FDA clearance for the Hugo robotic-assisted surgery system for urologic procedures in December 2025. Its U.S. commercial introduction provides hospitals with another major-manufacturer soft-tissue robotic option and creates potential for portfolio contracting across energy devices, stapling, instruments, and robotic technologies. Johnson & Johnson is separately advancing OTTAVA, creating another potential large-scale competitive platform if U.S. authorization is obtained.

Orthopedic robotics is evolving from fixed robotic arms toward multiple architectural models. Stryker expanded the Mako ecosystem with Mako 4 and in 2026 commercially launched Mako RPS, a handheld robotic power system for total knee replacement. Smith+Nephew’s CORI uses handheld robotics and a comparatively compact footprint. Zimmer Biomet is building a broader technology suite around ROSA, digital navigation, handheld solutions, and the autonomous-robotics capabilities acquired through Monogram Technologies. Competitive differentiation is therefore moving toward offering surgeons different levels of robotic assistance rather than imposing a single technical workflow.

Autonomy is emerging as a significant long-term innovation frontier. Zimmer Biomet’s acquisition of Monogram brought CT-based, AI-navigated semi-autonomous knee technology into a large orthopedic portfolio and created a development pathway toward more autonomous bone preparation. Full autonomy remains clinically and regulatorily demanding, but even limited automation could improve reproducibility, simplify repetitive procedural steps, and reduce dependence on manual execution.

Spine and neurosurgical navigation are also converging with robotics. Traditional optical and electromagnetic navigation platforms now compete with robotic trajectory guidance, intraoperative imaging, augmented visualization, and integrated implant workflows. Technologies such as Medtronic’s StealthStation and Mazor ecosystem, Globus Medical’s Excelsius platforms, Brainlab navigation solutions, and Alphatec’s expanding navigation architecture illustrate the strategic importance of controlling both procedural guidance and the implant workflow around it.

Endoluminal robotics represents another growth vector. Robotic bronchoscopy can support navigation into peripheral lung anatomy, where accurate access is essential for diagnosis. Intuitive reported approximately 144,100 Ion biopsy procedures in 2025, with the vast majority occurring in the United States. This installed-platform model can expand beyond capital sales as procedural utilization increases.

The final innovation layer is data. Future platforms will increasingly be differentiated by the ability to convert procedure data into planning support, utilization analytics, training feedback, video intelligence, workflow benchmarking, and decision-support applications. Hospitals are likely to favor technologies that connect with enterprise cybersecurity standards, imaging infrastructure, electronic records, and digital operating-room environments rather than functioning as isolated equipment.

 

Segmentation Insights

The U.S. Medical Robotics and Navigation Systems Market is segmented on the basis of product and system type, application, technology, end user, and geography.

 

By Product and System Type

Soft-Tissue Robotic Surgical Systems

Soft-tissue robotic systems represent the largest product category, accounting for an estimated USD 5.45 billion in 2025 when system revenue, robot-specific instruments, accessories, service, and associated recurring revenue are included. The category covers multiport and single-port robotic surgery across general surgery, urology, gynecology, colorectal surgery, thoracic surgery, and selected cardiac procedures.

The central economic advantage of the segment is its recurring-revenue architecture. An installed robot can generate instruments, accessories, service, upgrades, and software revenue across thousands of procedures during its usable life. Consequently, procedure growth and utilization rates are more important long-term indicators than annual system placements alone.

Orthopedic Robotic Systems

Orthopedic robotic systems generated an estimated USD 2.25 billion in 2025 and represent one of the fastest-growing categories. Systems support total knee, partial knee, hip, shoulder, and emerging spine workflows through planning, alignment, bone preparation, soft-tissue balancing, and execution assistance.

The segment is becoming highly competitive because Stryker, Zimmer Biomet, Smith+Nephew, Johnson & Johnson MedTech, THINK Surgical, and other companies connect robotics directly to their orthopedic implant strategies. This creates a different commercial model from soft-tissue robotics: robotic technology can influence implant pull-through, surgeon standardization, account conversion, and long-term orthopedic contracting.

Surgical Navigation Systems

Surgical navigation systems accounted for approximately USD 1.66 billion in 2025. The segment includes optical navigation, electromagnetic navigation, image-guided tracking, stereotactic systems, planning workstations, navigation instruments, and associated software.

Spine and neurosurgery remain major applications because millimeter-level localization is important around neural and vascular structures. Navigation is also widely used in ENT, orthopedic reconstruction, trauma, and selected interventional procedures. Growth will increasingly depend on software upgrades, automatic registration, intraoperative imaging integration, augmented visualization, and robotics connectivity.

Robotic Endoluminal and Endoscopic Platforms

Robotic endoluminal and endoscopic systems represented an estimated USD 1.07 billion in 2025. Robotic bronchoscopy is currently the most commercially established subsegment, supported by demand for peripheral pulmonary lesion access and lung-cancer diagnosis.

This segment is strategically attractive because a navigation or robotic platform can generate recurring procedure-specific catheter and accessory revenue. Future development may extend robotic control and computer-assisted navigation into additional natural-orifice diagnostic and therapeutic procedures.

Robotic Radiosurgery and Specialty Interventional Robotics

Robotic radiosurgery and specialty robotics generated approximately USD 1.42 billion in 2025. The category includes robotic radiosurgery, magnetic robotic navigation, selected catheter-based robotic interventions, and specialized procedural platforms that do not fit conventional soft-tissue, orthopedic, or endoluminal categories.

These systems address lower-volume but often high-value interventions. Their adoption depends heavily on specialty-center concentration, clinical differentiation, integration with imaging, procedure complexity, and the ability to justify capital expense through regional referral volumes.

 

By Application

General and Gastrointestinal Surgery

General and gastrointestinal surgery represent the largest addressable application pool. Robotic hernia repair, cholecystectomy, appendectomy, colorectal surgery, bariatric procedures, foregut surgery, and other abdominal operations provide substantial recurring procedure volume.

Growth is increasingly driven by benign procedures rather than solely complex cancer surgery. Hospitals with mature robotic programs typically seek to increase daily system utilization by adding high-volume general-surgery cases, reducing idle capacity, and standardizing training across surgical teams.

Urology and Gynecology

Urology and gynecology remain foundational robotic applications. Radical prostatectomy played a major role in the early adoption of robotic surgery in the United States, while hysterectomy and other gynecologic procedures continue to support substantial utilization.

The estimated 313,780 new U.S. prostate cancer cases in 2025 underline the scale of the urology opportunity. The segment is also strategically important because Medtronic’s initial U.S. Hugo clearance covers urologic procedures, directly increasing competitive intensity in a historically important robotic specialty.

Orthopedic Surgery

Orthopedic applications are led by total knee arthroplasty, partial knee arthroplasty, and total hip arthroplasty. Shoulder and spine applications are becoming increasingly important.

The U.S. has one of the world’s largest joint-replacement markets, supported by population aging, obesity, osteoarthritis, active older adults, and greater outpatient surgical capability. Hospitals and ASCs increasingly view robotics as part of an integrated orthopedic program involving implants, digital planning, patient engagement, intraoperative execution, and post-operative outcome tracking.

Spine and Neurosurgery

Spine and neurosurgery depend heavily on navigation because of complex three-dimensional anatomy and proximity to critical neurological structures. Robotic trajectory guidance is increasingly used for screw placement and other repetitive high-precision tasks.

The competitive environment increasingly centers on ecosystems combining imaging, navigation, robotics, implants, planning software, and intraoperative visualization. Integrated platforms can create substantial vendor lock-in because changing navigation architecture can affect surgeon workflow, instruments, implants, imaging connectivity, and staff training simultaneously.

Thoracic, Pulmonary, Cardiovascular, Radiosurgery and Other Applications

Thoracic and pulmonary applications are gaining strategic importance through robotic lung surgery and robotic bronchoscopy. The estimated 226,000-plus new U.S. lung and bronchus cancer cases in 2025 create a substantial clinical base for biopsy, diagnosis, staging, and surgical treatment.

Cardiovascular robotics remains smaller but technologically significant, particularly in catheter navigation and specialized interventions. Robotic radiosurgery contributes high-value oncology and neurosurgical demand. Together, these specialties provide diversification beyond the dominant general surgery, orthopedic, and urology markets.

 

By Technology

Teleoperated Multi-Arm Robotics

Teleoperated systems allow surgeons to control robotic instruments from a console while translating hand movement into precise instrument motion. This architecture dominates established soft-tissue robotics and benefits from extensive surgeon familiarity, large procedure libraries, and strong recurring instrument revenue.

Robotic-Arm and Handheld Execution Systems

These systems are particularly important in orthopedic surgery. Robotic arms can constrain instruments within a planned boundary, while handheld systems combine navigation and robotic control with familiar power-tool workflows. Handheld approaches are expected to gain relevance in ASCs because of smaller footprints and potentially lower infrastructure requirements.

Optical and Electromagnetic Navigation

Optical navigation uses tracked cameras and markers, while electromagnetic systems can provide tracking without continuous direct optical line-of-sight. Both technologies remain central to neurosurgery, spine, ENT, orthopedic surgery, and complex image-guided intervention.

Image-Integrated Robotic Navigation

This technology links navigation or robotic guidance with CT, fluoroscopy, MRI-derived planning, intraoperative 3D imaging, or other anatomical datasets. It supports more accurate registration, trajectory planning, implant positioning, and verification of procedural execution.

AI-Enabled and Semi-Autonomous Guidance

AI-enabled technologies represent the fastest-evolving technology layer. Applications include automated registration, anatomy segmentation, implant planning, image interpretation, procedure workflow recognition, surgical video analytics, alignment optimization, and selected semi-autonomous functions. Over time, this segment could shift economic value from mechanical hardware toward software-enabled procedural intelligence.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and health systems remain the dominant end users because they perform the majority of high-acuity robotic surgery, cancer surgery, neurosurgery, complex spine procedures, and multi-specialty interventions. Large integrated delivery networks increasingly negotiate robotics contracts at system level and may standardize platforms across multiple hospitals.

Their procurement criteria include clinical outcomes, utilization projections, operating-room efficiency, surgeon recruitment, vendor service capacity, cybersecurity, integration, capital structure, and lifetime cost per procedure.

Academic Medical Centers

Academic medical centers act as innovation hubs, training sites, clinical-trial centers, and early adopters. They are particularly important for next-generation soft-tissue robotics, advanced spine systems, autonomous orthopedic platforms, complex navigation, and robotic intervention.

Adoption at a major academic center can influence broader community-hospital demand because surgeons trained on a platform frequently seek continuity when entering independent practice.

Orthopedic, Spine and Specialty Surgical Hospitals

Specialty hospitals are strategically important because concentrated case volumes can support high robotic utilization. In orthopedics, high-volume joint-replacement programs can economically justify robotic technologies through implant-linked contracting, patient acquisition, surgeon productivity, and standardized pathways.

Ambulatory Surgery Centers

ASCs represent one of the highest-growth end-user groups. Robotics adoption remains concentrated in orthopedics and selected lower-acuity procedures, but the addressable opportunity is expanding as reimbursement, anesthesia practice, patient selection, and postoperative care improve.

ASC buyers generally prioritize compact footprint, rapid setup, portability, lower service cost, predictable disposable economics, and technology that can support several surgeons without requiring extensive infrastructure.

Cancer Centers and Specialized Interventional Facilities

Comprehensive cancer centers and specialized procedural centers create demand for robotic oncology surgery, robotic bronchoscopy, stereotactic navigation, radiosurgery, and other high-complexity systems. These organizations often evaluate technology on referral capture and clinical capability in addition to direct procedure economics.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Medical Robotics and Navigation Systems Market is geographically segmented into the South, West, Northeast, and Midwest. Regional demand varies according to population, surgical volumes, Medicare exposure, population age, hospital and ASC density, concentration of academic medical centers, orthopedic procedure rates, oncology burden, specialist recruitment, and willingness of health systems to fund premium capital technologies.

The South is the largest regional market, while the West is expected to record the fastest growth through 2035. The Northeast remains highly influential in complex procedures, academic adoption, clinical trials, and premium technology evaluation. The Midwest has particular strategic importance in orthopedics, spine, medtech manufacturing, and mature integrated health systems.

South

The South accounted for an estimated USD 4.32 billion in 2025, making it the largest regional medical robotics and navigation market. The region includes Texas, Florida, Georgia, North Carolina, Virginia, Maryland, Delaware, South Carolina, Tennessee, Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, West Virginia, and the District of Columbia. The South is projected to approach approximately USD 15.65 billion by 2035.

Population scale is a major structural advantage. Texas had approximately 31.7 million residents in 2025, while Florida had about 23.5 million, making them the second- and third-largest states nationally. Georgia and North Carolina each exceeded 11 million residents. Rapid migration into major Southern metropolitan areas is increasing both commercial-insurance and Medicare surgical volumes.

Texas is one of the two most important state markets nationally. Houston, Dallas-Fort Worth, Austin, and San Antonio contain large academic medical centers, integrated delivery networks, orthopedic groups, cancer programs, and surgical hospitals. Demand spans da Vinci programs, Mako and other orthopedic robotics, spine navigation, neurosurgery, interventional systems, and robotic bronchoscopy.

Florida is structurally attractive because of its large older-adult population. Joint replacement, urology, colorectal surgery, gynecology, thoracic surgery, spine procedures, and cancer intervention all benefit from the state’s Medicare-heavy population. Florida also has a large ASC base, increasing opportunity for compact orthopedic robotics and navigation systems.

North Carolina has a combination of population growth, major academic systems, research institutions, and strong specialty care infrastructure. Charlotte, Raleigh-Durham, Winston-Salem, and other markets support robotic surgery adoption across large integrated networks.

Georgia benefits from Atlanta’s position as a major regional referral market, while the state’s expanding population supports rising orthopedic, general-surgery, spine, and oncologic procedure volumes.

Virginia and Maryland have sophisticated provider markets around Northern Virginia, Richmond, Norfolk, Baltimore, and the Washington metropolitan region. Academic centers, defense-related medical infrastructure, high commercial-insurance penetration in major urban markets, and specialist density make these states important for advanced navigation and robotic adoption.

Tennessee has major hospital and healthcare-company clusters around Nashville, Memphis, Knoxville, and Chattanooga. The state combines large regional hospital systems with a strong ambulatory orthopedic opportunity. South Carolina is benefiting from population growth and retirement migration, which increases joint-replacement and age-related surgical demand.

Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and West Virginia have smaller premium-technology markets than Texas or Florida but significant chronic-disease and musculoskeletal burdens. Their opportunity is concentrated in regional referral centers, high-volume orthopedic programs, cancer centers, and health systems seeking to reduce the need for patients to travel to larger metropolitan markets.

Delaware and the District of Columbia are small in population but participate in dense Mid-Atlantic referral networks. Washington, D.C., in particular, has a high concentration of academic, specialty, and federal healthcare institutions.

Long term, the South should retain regional leadership because it combines population growth, aging, large hospital networks, expanding ASCs, and substantial room for additional robotics penetration outside major tertiary centers.

West

The West represented an estimated USD 2.76 billion in 2025 and is expected to be the fastest-growing region, reaching approximately USD 11.65 billion by 2035. The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the largest state market in the West and one of the largest medical robotics markets globally. Its 2025 population was approximately 39.4 million, the highest in the United States. The state has an exceptional concentration of academic medical centers, health systems, cancer centers, technology companies, venture-backed medtech firms, robotics developers, and minimally invasive surgery specialists.

California is particularly important for advanced soft-tissue robotics, robotic bronchoscopy, neurosurgical navigation, digital surgery, AI-enabled imaging, and early clinical evaluation. Its strong innovation ecosystem also makes the state important for technology development, not merely end-market consumption.

Washington and Oregon have sophisticated integrated health systems and strong adoption of digital workflow technologies. Seattle’s technology ecosystem is particularly relevant as robotic systems become increasingly software intensive.

Arizona and Nevada are among the strongest population-growth and retirement markets. Aging populations support orthopedic procedures, urology, spine surgery, and cancer intervention. Phoenix is increasingly important for large health-system investment, while Las Vegas continues to develop higher-acuity local care infrastructure.

Colorado combines population growth with strong specialty medicine and integrated delivery networks. Denver and surrounding markets provide attractive demand for orthopedic robotics, navigation, spine systems, and advanced minimally invasive surgery.

Utah is smaller in population but benefits from sophisticated provider networks, strong technology adoption, and regional referral capability. Its younger average population moderates some age-related demand, but high procedural efficiency and integrated systems make it commercially important.

Idaho and Montana have smaller installed bases but are growing markets as regional hospitals expand specialty capability. Navigation and smaller-footprint robotics can help these facilities retain surgical patients who might otherwise travel to larger metropolitan centers.

New Mexico and Wyoming have more limited high-acuity infrastructure outside major referral centers, making capital placement highly dependent on procedure concentration. Alaska and Hawaii face geographic isolation and unique referral patterns; their markets are smaller but strategically suited to technologies that enable high-complexity procedures at major regional centers.

The West should gain national share through 2035 because it combines rapid population growth in several states, early technology adoption, strong medtech innovation, high-value hospital networks, and growing integration of AI into procedural systems.

Northeast

The Northeast accounted for an estimated USD 2.49 billion in 2025 and is projected to reach approximately USD 8.31 billion by 2035. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Maine, New Hampshire, and Vermont.

The Northeast does not lead national population growth, but its clinical intensity is unusually high. The region contains a dense concentration of academic medical centers, major cancer institutions, teaching hospitals, specialist groups, and clinical-trial sites.

New York, with approximately 20.0 million residents in 2025, is the region’s largest market. New York City alone has multiple high-volume academic systems operating large robotic surgery programs across urology, gynecology, general surgery, thoracic surgery, colorectal surgery, oncology, neurosurgery, and orthopedics. Upstate regional systems create an additional market for orthopedic robotics, navigation, and specialty referral programs.

Pennsylvania, with approximately 13.1 million residents, combines major academic centers in Philadelphia and Pittsburgh with a large community and regional hospital base. It is particularly important for spine, neurosurgery, orthopedic robotics, robotic general surgery, and cancer care.

New Jersey benefits from population density, high commercial-insurance penetration, proximity to both New York and Philadelphia, major integrated systems, and a growing ambulatory surgery sector. The state’s high-income patient base and competitive hospital environment support adoption of technologies that can improve surgeon recruitment and patient differentiation.

Massachusetts is disproportionately influential relative to its population because Boston is one of the world’s most important academic medicine, biotechnology, and medical-device innovation clusters. Novel robotics, navigation, AI-assisted procedural tools, and clinical evidence programs frequently gain early evaluation in this market.

Connecticut supports a sophisticated hospital and ambulatory environment and benefits from proximity to the New York and Boston healthcare corridors. Rhode Island is smaller but anchored by regional academic and referral facilities.

Maine, New Hampshire, and Vermont represent smaller state markets characterized by more dispersed populations and lower system-placement volumes. Their opportunity is strongest in regional referral centers where navigation or robotics can expand local procedural capability and reduce patient travel.

Northeastern health systems tend to have rigorous technology-assessment processes. Clinical evidence, comparative outcomes, cybersecurity, integration, surgeon credentialing, and budget impact can be as important as technical specifications. This creates higher barriers for new entrants but also produces strong reference accounts when adoption occurs.

Midwest

The Midwest represented approximately USD 2.28 billion in 2025 and is expected to reach around USD 6.99 billion by 2035. The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

The Midwest is especially important in orthopedic robotics, spine, hospital-system standardization, and medical-device innovation. The region has mature surgical infrastructure and several internationally influential health systems.

Illinois had approximately 12.7 million residents in 2025, with Chicago serving as a major academic and referral market. Demand is diversified across soft-tissue robotics, robotic bronchoscopy, orthopedic robotics, neurosurgical navigation, spine, and oncology.

Ohio, with approximately 11.9 million residents, has exceptional specialist and tertiary-care infrastructure. Cleveland, Columbus, and Cincinnati support large procedural markets. The first U.S. surgery using Medtronic’s newly FDA-cleared Hugo system was performed at Cleveland Clinic in 2026, illustrating Ohio’s role in early technology deployment.

Michigan combines a population above 10 million with major integrated healthcare systems, advanced orthopedic programs, and a strong medical-technology heritage. Indiana has significant orthopedic and spine activity and benefits from a strong device-manufacturing ecosystem.

Minnesota is strategically distinctive because it is one of the world’s major medical-technology clusters. Its hospitals and academic centers interact closely with medtech developers, making the state important for robotics, navigation, cardiovascular intervention, and digital operating-room innovation.

Wisconsin and Missouri provide stable demand across large metropolitan and regional health systems. Milwaukee, Madison, St. Louis, and Kansas City support sophisticated robotic and navigation programs.

Iowa, Kansas, and Nebraska have smaller populations but important regional referral systems serving large geographic catchments. Robotics investment in these states frequently depends on concentrating procedures at major centers to maximize utilization.

North Dakota and South Dakota are relatively small markets but can benefit from navigation and robotic technologies that allow regional centers to maintain higher-acuity orthopedic, spine, neurosurgical, and general-surgery programs.

The Midwest is expected to grow below the national average because of slower population expansion, but its strong orthopedic market, established hospital systems, specialist concentration, and medtech ecosystem will sustain a substantial long-term revenue base.

 

Key Market Players

The U.S. Medical Robotics and Navigation Systems Competitive Landscape is concentrated around a small number of highly scaled platforms but remains fragmented by specialty. Intuitive Surgical dominates established soft-tissue robotic surgery, while Stryker is highly influential in orthopedic robotics. Medtronic and Globus Medical hold important positions in spine and navigation, Zimmer Biomet and Smith+Nephew compete strongly in orthopedic robotics, and Brainlab has a major presence in surgical navigation and digital guidance.

Some of the key companies participating in the U.S. Medical Robotics and Navigation Systems industry include:

Intuitive Surgical; Stryker; Medtronic; Zimmer Biomet; Johnson & Johnson MedTech; Globus Medical; Smith+Nephew; Brainlab; Siemens Healthineers; GE HealthCare; Philips; Accuray; Stereotaxis; PROCEPT BioRobotics; THINK Surgical; Alphatec Holdings; Augmedics; KARL STORZ; Moon Surgical; Renishaw; OrthAlign; CMR Surgical; Vicarious Surgical; Elekta; and Microbot Medical.

Competition increasingly revolves around ecosystem economics rather than robot specifications alone. Soft-tissue vendors compete on procedure libraries, instruments, surgeon training, visualization, service uptime, and recurring economics. Orthopedic companies compete simultaneously on robotics and implant pull-through. Spine companies integrate navigation, implants, biologics, imaging, and robotic guidance. Navigation specialists compete through open architecture, interoperability, visualization, and software.

Intuitive remains the single largest revenue contributor to the defined U.S. market, supported by approximately USD 6.82 billion of U.S. revenue in 2025. However, its leadership is concentrated in soft-tissue robotics and robotic bronchoscopy rather than orthopedic or spine robotics, making the total competitive ecosystem considerably more diverse than the soft-tissue category alone.

Market-share shifts through 2035 will depend on FDA clearances, procedure expansion, instrument portfolios, system reliability, clinical evidence, installed-base productivity, ASC economics, software capability, AI development, hospital contracting, financing, and surgeon preference. New systems will need to displace both conventional surgery and incumbent robotic platforms, making switching economics as important as technological performance.

 

Recent Developments

The U.S. medical robotics market entered a significant competitive cycle during 2025–2026 as multiple manufacturers expanded their regulatory and commercial positions.

In December 2025, Medtronic received U.S. FDA clearance for the Hugo robotic-assisted surgery system for urologic procedures, introducing a major new soft-tissue robotic competitor into the U.S. market. In February 2026, the first U.S. procedure using Hugo was performed at Cleveland Clinic. Medtronic subsequently advanced additional U.S. submissions aimed at expanding the system into general and gynecologic surgery.

Johnson & Johnson advanced its OTTAVA robotic surgical system by submitting the technology to the FDA in January 2026 for De Novo classification based on clinical study data in general surgery. The company had previously received an Investigational Device Exemption allowing U.S. clinical evaluation. Successful commercialization would materially increase competition because Johnson & Johnson can potentially connect robotics with one of the industry’s broadest surgical-device portfolios.

Orthopedic robotics also accelerated. Zimmer Biomet completed its acquisition of Monogram Technologies in October 2025, adding CT-based, AI-navigated semi-autonomous robotic capabilities and a pathway toward more autonomous orthopedic surgery. The acquired knee platform had received U.S. FDA 510(k) clearance in March 2025. Zimmer Biomet also continued upgrading its ROSA ecosystem, including regulatory progress around enhanced knee robotics.

In July 2026, Stryker commercially launched Mako RPS in the United States for total knee replacement. The system introduces a handheld robotic execution model alongside the company’s established robotic-arm architecture. The development demonstrates an important market shift: major vendors increasingly expect customers to choose among several levels and form factors of robotic assistance.

Spine robotics and navigation experienced similar expansion. In February 2026, Alphatec received U.S. clearance for its Valence Robotic Navigation System, designed for use with StealthStation. Medtronic continued updating StealthStation software and integrating navigation with its broader spine enabling-technology ecosystem. Globus Medical is similarly advancing robotic and navigation integration around its musculoskeletal portfolio.

AI is becoming more visible across the operating-room workflow. Manufacturers are introducing real-time computing, video analytics, automatic planning, enhanced registration, instrument tracking, and digital decision-support capabilities. The next competitive phase is therefore expected to be defined not solely by mechanical robotics but by how successfully companies integrate robotics, imaging, navigation, software, data, and AI into a unified clinical workflow.

 

Conclusion

The U.S. Medical Robotics and Navigation Systems Market Size & Share is positioned for high-growth expansion from approximately USD 11.85 billion in 2025 to USD 42.60 billion by 2035, representing a 13.65% CAGR during 2026–2035.

Unlike earlier adoption cycles, future market growth will not depend primarily on hospitals purchasing their first robot. The U.S. already has a large installed base across soft-tissue surgery, orthopedics, spine, neurosurgery, robotic bronchoscopy, and navigation. Growth will increasingly come from higher utilization, replacement cycles, additional robotic rooms, expanded procedure indications, recurring instruments, software, service contracts, ASC adoption, and integration of AI-enabled functionality.

Soft-tissue robotic surgery will remain the largest value pool, supported by high procedure volumes and strong recurring economics. Orthopedic robotics should remain one of the fastest-growing categories as knee, hip, shoulder, and spine workflows become increasingly digital. Surgical navigation will remain essential in neurosurgery, spine, ENT, and complex orthopedic procedures while increasingly converging with robotics and intraoperative imaging. Endoluminal robotics and robotic bronchoscopy add an important diagnostic-interventional growth layer.

From a procurement perspective, the critical issue for U.S. hospitals is shifting from whether robotic technology works to whether a particular platform generates sufficient clinical and economic value for its service line. Systems that increase procedure capture, improve asset utilization, support multiple specialties, integrate into existing digital infrastructure, and create predictable per-procedure economics will have a structural advantage.

The South will remain the largest regional market because of its combination of population scale, rapid migration, aging demographics, hospital-system expansion, and growing ASC penetration. The West should achieve the fastest growth because of technology adoption, demographic expansion in several states, and its innovation ecosystem. The Northeast will retain an outsized role in academic adoption and complex procedures, while the Midwest will remain essential in orthopedics, spine, medical-device innovation, and mature health-system procurement.

At the state level, California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, Georgia, North Carolina, Michigan, New Jersey, Massachusetts, Arizona, Washington, Virginia, Minnesota, and Tennessee will be particularly important commercial markets. However, vendors that develop lower-footprint, flexible and economically scalable systems will increasingly find growth beyond these major states as community hospitals and ASCs seek to retain complex surgical cases locally.

For clients evaluating this market, the most important strategic question is not simply which company currently sells the largest number of robotic systems. The more consequential question is which platforms can create durable procedure ecosystems. The strongest competitive positions through 2035 will belong to companies that combine clinically useful robotics, high-value navigation, recurring procedural revenue, broad indications, hospital-friendly economics, scalable training, strong service infrastructure, AI-enabled software, regulatory execution, and measurable improvements in clinical workflow.

 

TABLE OF CONTENT

1. U.S. Medical Robotics and Navigation Systems Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Market Boundary and Revenue Inclusion Framework
1.6.1. Robotic Capital Systems
1.6.2. Surgical Navigation Hardware and Software
1.6.3. Robotic Instruments and Accessories
1.6.4. Procedure-Specific Consumables and Disposables
1.6.5. Service, Maintenance and Software Revenue
1.6.6. Excluded Conventional Surgical and Imaging Equipment
1.7. Stakeholder Analysis
1.7.1. Medical Robotic System Manufacturers
1.7.2. Surgical Navigation and Image-Guidance Companies
1.7.3. Component, Sensor, Optics and Contract Manufacturing Suppliers
1.7.4. Hospitals and Integrated Delivery Networks
1.7.5. Academic Medical Centers and Teaching Hospitals
1.7.6. Ambulatory Surgery Centers and Specialty Surgical Hospitals
1.7.7. Surgeons, Clinical Specialists and Operating Room Teams
1.7.8. Group Purchasing Organizations and Distribution Partners
1.7.9. Payers, Regulators and Health Technology Assessment Stakeholders

What this section provides: This section defines the market boundary, revenue scope, methodology, assumptions, validation process, and stakeholder ecosystem so clients understand precisely how the U.S. medical robotics and navigation systems market is measured.

2. U.S. Medical Robotics and Navigation Systems Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. U.S. Installed Base and Procedure Utilization Snapshot
2.8. Capital Equipment vs. Recurring Revenue Analysis
2.9. High-Growth Opportunity Areas
2.10. Key Investment and Commercialization Themes

What this section provides: This section gives decision-makers a concise view of market size, historical performance, forecast growth, installed-base economics, recurring revenue potential, competitive intensity, and priority opportunity areas through 2035.

3. U.S. Medical Robotics and Navigation Systems Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Adoption of Minimally Invasive and Precision-Guided Surgery
3.1.2. Increasing Robotic General Surgery Procedure Volumes
3.1.3. Expansion of Robotic Orthopedic Joint Replacement
3.1.4. Growing Use of Navigation and Robotics in Spine and Neurosurgery
3.1.5. Aging U.S. Population and Rising Surgical Intervention Requirements
3.1.6. Hospital Competition for High-Value Surgical Service Lines
3.1.7. Expansion of Robotic Surgery into Ambulatory Surgery Centers
3.1.8. Growth of Robotic Bronchoscopy and Endoluminal Intervention

3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Acquisition and Lifecycle Costs
3.2.2. Lack of Dedicated Reimbursement Premium for Robotic Assistance
3.2.3. Procedure-Volume Requirements for Positive Return on Investment
3.2.4. Surgeon Training and Learning-Curve Requirements
3.2.5. Operating Room Footprint and Infrastructure Constraints
3.2.6. Maintenance, Service Contract and Instrument Cost Burden
3.2.7. Cybersecurity and Connected-System Risks

3.3. Opportunities and Their Impact Analysis
3.3.1. Multi-Specialty Robotic Platform Expansion
3.3.2. Handheld and Compact Robotic Systems for ASCs
3.3.3. AI-Enabled Surgical Planning and Intraoperative Guidance
3.3.4. Semi-Autonomous and Autonomous Robotic Functions
3.3.5. Software and Analytics-Based Recurring Revenue Models
3.3.6. Robotic Bronchoscopy and Natural-Orifice Intervention
3.3.7. Imaging-Robotics-Navigation Integration
3.3.8. Robotic Surgery Penetration in Community Hospitals

3.4. Challenges and Their Impact Analysis
3.4.1. Demonstrating Incremental Clinical Value vs. Conventional Surgery
3.4.2. Hospital Capital Budget Competition
3.4.3. Platform Lock-In and Switching Costs
3.4.4. Credentialing and Workforce Availability
3.4.5. Data Interoperability and Vendor Integration

3.5. Patent & Innovation Analysis, 2021–2025
3.6. Medical Robotics Innovation Cycle Analysis
3.7. Clinical Workflow Economics Analysis
3.8. Cost per Procedure and Utilization Economics
3.9. Hospital Capital Procurement Behavior Analysis
3.10. Surgeon Adoption and Platform Preference Analysis
3.11. ASC Adoption Readiness Analysis

What this section provides: This section explains the clinical, technological, reimbursement, procurement, utilization, and economic forces shaping demand while identifying both the growth opportunities and adoption barriers affecting robotics and navigation systems.

4. U.S. Medical Robotics and Navigation Systems Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Hospital and Health System Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry

4.3. Robotic System Pricing Trend Analysis, 2025–2035
4.4. Instruments, Accessories and Consumables Pricing Analysis
4.5. Service and Maintenance Contract Economics
4.6. Value Chain & Supply Chain Analysis
4.7. Medical Robotics Component Ecosystem
4.7.1. Robotic Arms and Actuation Systems
4.7.2. Sensors and Tracking Technologies
4.7.3. Cameras, Optics and Visualization Components
4.7.4. Navigation Workstations and Computing Systems
4.7.5. Software, AI and Analytics Platforms
4.7.6. Surgical Instruments and End Effectors

4.8. Application & Innovation Landscape
4.9. FDA Regulatory Framework Analysis
4.9.1. 510(k) Pathway
4.9.2. De Novo Pathway
4.9.3. Premarket Approval Considerations
4.9.4. Software and AI Regulatory Considerations
4.9.5. Robotic System Modification and Supplemental Clearances

4.10. CMS Reimbursement and Coverage Landscape
4.11. Hospital Capital Budget and ROI Framework
4.12. Group Purchasing and Enterprise Contracting Dynamics
4.13. Impact of Digital Surgery and Connected Operating Rooms
4.14. AI and Surgical Data Governance
4.15. Cybersecurity Requirements for Connected Robotic Systems
4.16. Import/Export Restrictions & Tariff Impact
4.17. U.S. Manufacturing and Supply Chain Localization
4.18. Impact of Escalating Geopolitical Tensions
4.19. Hospital Value Analysis Committee Decision Framework

What this section provides: This section gives clients a comprehensive view of regulation, reimbursement, pricing, supply chains, robotic technology economics, AI adoption, cybersecurity, hospital procurement, and external forces influencing the U.S. industry.

5. U.S. Medical Robotics and Navigation Systems Market – By Product & System Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product & System Type, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)

5.2. Soft-Tissue Robotic Surgical Systems
5.2.1. Multiport Robotic Surgical Systems
5.2.2. Single-Port Robotic Surgical Systems
5.2.3. Modular Robotic Surgical Systems
5.2.4. Robotic Instruments and Accessories
5.2.5. Software, Service and Procedure-Linked Revenue

5.3. Orthopedic Robotic Systems
5.3.1. Robotic Knee Surgery Systems
5.3.2. Robotic Hip Surgery Systems
5.3.3. Robotic Shoulder Surgery Systems
5.3.4. Handheld Orthopedic Robotic Systems
5.3.5. Implant-Integrated Robotic Platforms

5.4. Surgical Navigation Systems
5.4.1. Spine Navigation Systems
5.4.2. Neurosurgical Navigation Systems
5.4.3. Orthopedic Navigation Systems
5.4.4. ENT Navigation Systems
5.4.5. Multi-Specialty Navigation Platforms

5.5. Robotic Endoluminal and Endoscopic Platforms
5.5.1. Robotic Bronchoscopy Systems
5.5.2. Robotic Endoscopic Navigation Systems
5.5.3. Natural-Orifice Robotic Platforms
5.5.4. Procedure-Specific Robotic Catheters and Accessories

5.6. Robotic Radiosurgery and Specialty Interventional Robotics
5.6.1. Robotic Radiosurgery Systems
5.6.2. Robotic Catheter Navigation Systems
5.6.3. Specialty Interventional Robotic Platforms
5.6.4. Other Emerging Medical Robotic Systems

What this section provides: This section identifies the robotic and navigation product categories generating the largest revenue pools, highest recurring revenue, fastest procedure adoption, and strongest commercial opportunities through 2035.

6. U.S. Medical Robotics and Navigation Systems Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)

6.2. General and Gastrointestinal Surgery
6.2.1. Hernia Repair
6.2.2. Cholecystectomy
6.2.3. Colorectal Surgery
6.2.4. Bariatric Surgery
6.2.5. Foregut Surgery
6.2.6. Other General Surgical Procedures

6.3. Urology and Gynecology
6.3.1. Prostatectomy
6.3.2. Partial and Radical Nephrectomy
6.3.3. Cystectomy
6.3.4. Hysterectomy
6.3.5. Gynecologic Oncology
6.3.6. Other Urologic and Gynecologic Procedures

6.4. Orthopedic Surgery
6.4.1. Total Knee Arthroplasty
6.4.2. Partial Knee Arthroplasty
6.4.3. Total Hip Arthroplasty
6.4.4. Shoulder Arthroplasty
6.4.5. Other Orthopedic Applications

6.5. Spine and Neurosurgery
6.5.1. Spinal Fusion and Instrumentation
6.5.2. Pedicle Screw Placement
6.5.3. Cranial Navigation
6.5.4. Neurosurgical Biopsy and Tumor Procedures
6.5.5. Stereotactic Procedures
6.5.6. Other Spine and Neurosurgical Applications

6.6. Thoracic, Pulmonary, Cardiovascular, Radiosurgery and Other Applications
6.6.1. Thoracic Robotic Surgery
6.6.2. Robotic Bronchoscopy and Lung Biopsy
6.6.3. Cardiovascular Robotic Intervention
6.6.4. Robotic Radiosurgery
6.6.5. ENT Procedures
6.6.6. Other Emerging Applications

What this section provides: This section helps clients identify clinical procedure areas with the strongest robotic utilization, navigation intensity, recurring instrument demand, and long-term addressable procedure opportunity.

7. U.S. Medical Robotics and Navigation Systems Market – By Technology

7.1. Overview
7.1.1. Segment Share Analysis, By Technology, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)

7.2. Teleoperated Multi-Arm Robotic Systems
7.2.1. Console-Based Systems
7.2.2. Modular Multi-Arm Platforms
7.2.3. Single-Port Teleoperated Platforms

7.3. Robotic-Arm and Handheld Execution Systems
7.3.1. Fixed Robotic-Arm Systems
7.3.2. Handheld Robotic Systems
7.3.3. Haptic Boundary-Controlled Robotics
7.3.4. Robotically Controlled Surgical Power Tools

7.4. Optical and Electromagnetic Navigation
7.4.1. Optical Tracking Systems
7.4.2. Electromagnetic Tracking Systems
7.4.3. Hybrid Navigation Technologies
7.4.4. Instrument Tracking and Registration Platforms

7.5. Image-Integrated Robotic Navigation
7.5.1. CT-Based Navigation
7.5.2. Fluoroscopy-Based Navigation
7.5.3. Intraoperative 3D Imaging Integration
7.5.4. MRI and Multimodal Image-Guided Navigation
7.5.5. Augmented Visualization and Navigation

7.6. AI-Enabled and Semi-Autonomous Guidance
7.6.1. AI-Based Surgical Planning
7.6.2. Automated Registration and Anatomy Recognition
7.6.3. Robotic Workflow Intelligence
7.6.4. Semi-Autonomous Surgical Execution
7.6.5. Autonomous Robotic Technology Development
7.6.6. Surgical Video and Procedure Analytics

What this section provides: This section evaluates the underlying technologies transforming medical robotics, from teleoperation and navigation to AI-enabled planning, robotic execution, automation, and next-generation digital surgery.

8. U.S. Medical Robotics and Navigation Systems Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

8.2. Hospitals and Integrated Health Systems
8.2.1. Large Integrated Delivery Networks
8.2.2. Community Hospitals
8.2.3. Regional Referral Hospitals
8.2.4. Multi-Hospital Robotic Surgery Programs

8.3. Academic Medical Centers and Teaching Hospitals
8.3.1. Academic Surgical Programs
8.3.2. Robotics Training and Fellowship Centers
8.3.3. Clinical Trial and Technology Evaluation Centers

8.4. Orthopedic, Spine and Specialty Surgical Hospitals
8.4.1. Orthopedic Specialty Hospitals
8.4.2. Spine Surgery Centers
8.4.3. Specialty Surgical Institutions

8.5. Ambulatory Surgery Centers
8.5.1. Orthopedic ASCs
8.5.2. Multi-Specialty ASCs
8.5.3. Hospital-Owned ASCs
8.5.4. Independent Physician-Owned ASCs

8.6. Cancer Centers and Specialized Interventional Facilities
8.6.1. Comprehensive Cancer Centers
8.6.2. Pulmonary and Thoracic Intervention Centers
8.6.3. Radiosurgery Centers
8.6.4. Other Specialized Procedural Facilities

What this section provides: This section identifies the customer groups driving capital purchases, recurring procedure revenue, platform utilization, technology replacement, and future robotic adoption across hospital and outpatient settings.

9. U.S. Medical Robotics and Navigation Systems Market – By Geography

9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
9.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
9.1.3. Regional Robotic Procedure Volume Analysis
9.1.4. Regional Installed Base Analysis
9.1.5. Regional Hospital and ASC Infrastructure Analysis
9.1.6. Regional Capital Procurement and Technology Adoption Dynamics
9.1.7. Regional Surgeon Density and Specialty Procedure Analysis

9.2. West Region

9.2.1. Regional Overview & Trends
9.2.2. West Region Medical Robotics and Navigation Key Manufacturers and Procurement Ecosystem
9.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.2.4. West Region Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.6. West Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.8. West Region Robotic Installed Base and Procedure Utilization Analysis

9.2.9. California

9.2.9.1. Overview
9.2.9.2. California Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.9.4. California Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.2.10. Washington

9.2.10.1. Overview
9.2.10.2. Washington Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.10.4. Washington Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.2.11. Arizona

9.2.11.1. Overview
9.2.11.2. Arizona Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.11.4. Arizona Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.2.12. Colorado

9.2.12.1. Overview
9.2.12.2. Colorado Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.12.4. Colorado Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.2.13. Oregon

9.2.13.1. Overview
9.2.13.2. Oregon Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.13.4. Oregon Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.2.14. Utah

9.2.14.1. Overview
9.2.14.2. Utah Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.14.4. Utah Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.2.15. Nevada

9.2.15.1. Overview
9.2.15.2. Nevada Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.15.4. Nevada Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.2.16. New Mexico

9.2.16.1. Overview
9.2.16.2. New Mexico Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.16.4. New Mexico Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.2.17. Idaho

9.2.17.1. Overview
9.2.17.2. Idaho Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.17.4. Idaho Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.2.18. Montana

9.2.18.1. Overview
9.2.18.2. Montana Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.18.4. Montana Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.2.19. Wyoming

9.2.19.1. Overview
9.2.19.2. Wyoming Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.19.4. Wyoming Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.2.20. Alaska

9.2.20.1. Overview
9.2.20.2. Alaska Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.20.4. Alaska Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.2.21. Hawaii

9.2.21.1. Overview
9.2.21.2. Hawaii Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.21.4. Hawaii Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.3. Northeast Region

9.3.1. Regional Overview & Trends
9.3.2. Northeast Region Medical Robotics and Navigation Key Manufacturers and Procurement Ecosystem
9.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.3.4. Northeast Region Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.6. Northeast Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.8. Northeast Region Robotic Installed Base and Procedure Utilization Analysis

9.3.9. New York

9.3.9.1. Overview
9.3.9.2. New York Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.9.4. New York Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.3.10. Massachusetts

9.3.10.1. Overview
9.3.10.2. Massachusetts Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.10.4. Massachusetts Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.3.11. New Jersey

9.3.11.1. Overview
9.3.11.2. New Jersey Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.11.4. New Jersey Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.3.12. Pennsylvania

9.3.12.1. Overview
9.3.12.2. Pennsylvania Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.12.4. Pennsylvania Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.3.13. Connecticut

9.3.13.1. Overview
9.3.13.2. Connecticut Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.13.4. Connecticut Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.3.14. Maine

9.3.14.1. Overview
9.3.14.2. Maine Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.14.4. Maine Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.3.15. Vermont

9.3.15.1. Overview
9.3.15.2. Vermont Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.15.4. Vermont Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.3.16. New Hampshire

9.3.16.1. Overview
9.3.16.2. New Hampshire Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.16.4. New Hampshire Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.3.17. Rhode Island

9.3.17.1. Overview
9.3.17.2. Rhode Island Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.17.4. Rhode Island Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.3.18. Delaware

9.3.18.1. Overview
9.3.18.2. Delaware Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.18.4. Delaware Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4. South Region

9.4.1. Regional Overview & Trends
9.4.2. South Region Medical Robotics and Navigation Key Manufacturers and Procurement Ecosystem
9.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.4.4. South Region Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.6. South Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.8. South Region Robotic Installed Base and Procedure Utilization Analysis

9.4.9. Texas

9.4.9.1. Overview
9.4.9.2. Texas Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.9.4. Texas Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.10. Florida

9.4.10.1. Overview
9.4.10.2. Florida Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.10.4. Florida Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.11. Georgia

9.4.11.1. Overview
9.4.11.2. Georgia Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.11.4. Georgia Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.12. North Carolina

9.4.12.1. Overview
9.4.12.2. North Carolina Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.12.4. North Carolina Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.13. Tennessee

9.4.13.1. Overview
9.4.13.2. Tennessee Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.13.4. Tennessee Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.14. South Carolina

9.4.14.1. Overview
9.4.14.2. South Carolina Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.14.4. South Carolina Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.15. Alabama

9.4.15.1. Overview
9.4.15.2. Alabama Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.15.4. Alabama Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.16. Mississippi

9.4.16.1. Overview
9.4.16.2. Mississippi Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.16.4. Mississippi Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.17. Louisiana

9.4.17.1. Overview
9.4.17.2. Louisiana Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.17.4. Louisiana Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.18. Arkansas

9.4.18.1. Overview
9.4.18.2. Arkansas Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.18.4. Arkansas Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.19. Kentucky

9.4.19.1. Overview
9.4.19.2. Kentucky Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.19.4. Kentucky Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.20. Oklahoma

9.4.20.1. Overview
9.4.20.2. Oklahoma Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.20.4. Oklahoma Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.21. Virginia

9.4.21.1. Overview
9.4.21.2. Virginia Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.21.4. Virginia Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.22. Maryland

9.4.22.1. Overview
9.4.22.2. Maryland Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.22.4. Maryland Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.4.23. West Virginia

9.4.23.1. Overview
9.4.23.2. West Virginia Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.23.4. West Virginia Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.5. Midwest Region

9.5.1. Regional Overview & Trends
9.5.2. Midwest Region Medical Robotics and Navigation Key Manufacturers and Procurement Ecosystem
9.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.5.4. Midwest Region Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.6. Midwest Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.8. Midwest Region Robotic Installed Base and Procedure Utilization Analysis

9.5.9. Illinois

9.5.9.1. Overview
9.5.9.2. Illinois Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.9.4. Illinois Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.5.10. Ohio

9.5.10.1. Overview
9.5.10.2. Ohio Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.10.4. Ohio Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.5.11. Michigan

9.5.11.1. Overview
9.5.11.2. Michigan Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.11.4. Michigan Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.5.12. Minnesota

9.5.12.1. Overview
9.5.12.2. Minnesota Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.12.4. Minnesota Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.5.13. Indiana

9.5.13.1. Overview
9.5.13.2. Indiana Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.13.4. Indiana Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.5.14. Wisconsin

9.5.14.1. Overview
9.5.14.2. Wisconsin Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.14.4. Wisconsin Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.5.15. Missouri

9.5.15.1. Overview
9.5.15.2. Missouri Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.15.4. Missouri Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.5.16. Iowa

9.5.16.1. Overview
9.5.16.2. Iowa Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.16.4. Iowa Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.5.17. Kansas

9.5.17.1. Overview
9.5.17.2. Kansas Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.17.4. Kansas Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.5.18. Nebraska

9.5.18.1. Overview
9.5.18.2. Nebraska Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.18.4. Nebraska Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.5.19. North Dakota

9.5.19.1. Overview
9.5.19.2. North Dakota Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.19.4. North Dakota Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

9.5.20. South Dakota

9.5.20.1. Overview
9.5.20.2. South Dakota Market Size and Forecast, By Product & System Type, 2021–2035 (US$ Billion)
9.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.20.4. South Dakota Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
9.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis across all 50 U.S. states, helping clients identify robotic procedure hubs, installed-base concentrations, capital investment hotspots, ASC opportunities, adoption patterns, and priority commercial markets.

10. U.S. Medical Robotics and Navigation Systems Market: Competitive Landscape & Company Profiles

10.1. Market Share Analysis, 2025
10.2. Competitive Benchmarking by Robotics and Navigation Segment
10.3. Company Positioning Matrix
10.3.1. Leaders
10.3.2. Challengers
10.3.3. Innovators
10.3.4. Emerging Players

10.4. Competitive Strategy Analysis
10.4.1. Installed Base Strategy
10.4.2. Recurring Instruments and Accessories Strategy
10.4.3. Implant Pull-Through Strategy
10.4.4. Software and Digital Surgery Strategy
10.4.5. Hospital Enterprise Contracting Strategy
10.4.6. ASC Commercialization Strategy
10.4.7. Surgeon Training and Ecosystem Development

10.5. Company Profiles

10.5.1. Intuitive Surgical
10.5.2. Stryker
10.5.3. Medtronic
10.5.4. Zimmer Biomet
10.5.5. Johnson & Johnson MedTech
10.5.6. Globus Medical
10.5.7. Smith+Nephew
10.5.8. Brainlab
10.5.9. Siemens Healthineers
10.5.10. GE HealthCare
10.5.11. Philips
10.5.12. Accuray
10.5.13. Stereotaxis
10.5.14. PROCEPT BioRobotics
10.5.15. THINK Surgical
10.5.16. Alphatec Holdings
10.5.17. Augmedics
10.5.18. KARL STORZ
10.5.19. Moon Surgical
10.5.20. Renishaw
10.5.21. OrthAlign
10.5.22. CMR Surgical
10.5.23. Vicarious Surgical
10.5.24. Elekta
10.5.25. Microbot Medical

Note: Each company profile will include company overview, medical robotics and navigation portfolio, relevant U.S. installed-base strategy, U.S. market presence, financial positioning, procedural ecosystem strategy, FDA regulatory developments, clinical pipeline, partnerships, acquisitions, software capabilities, and recent developments.

What this section provides: This section gives clients market-share visibility, competitor benchmarking, platform positioning, installed-base strategy, recurring revenue intelligence, pipeline analysis, and strategic profiles of 25 important medical robotics and navigation companies.

11. U.S. Medical Robotics and Navigation Systems Market: Future Market Outlook, 2026–2035

11.1. Scenario Analysis
11.1.1. Optimistic Scenario
11.1.2. Realistic Scenario
11.1.3. Pessimistic Scenario

11.2. Disruptive Technologies Impact
11.2.1. Next-Generation Multi-Specialty Robotic Platforms
11.2.2. AI-Enabled Surgical Guidance
11.2.3. Semi-Autonomous Robotic Surgery
11.2.4. Autonomous Surgical Robotics
11.2.5. Augmented and Mixed Reality Navigation
11.2.6. Image-Free and Imageless Robotic Navigation
11.2.7. Robotic Bronchoscopy and Endoluminal Robotics
11.2.8. Surgical Video Intelligence and Analytics
11.2.9. Digital Twins and Patient-Specific Surgical Planning
11.2.10. Connected and Data-Driven Operating Rooms

11.3. Emerging Business Trends
11.3.1. Hardware-to-Platform Business Model Shift
11.3.2. Recurring Procedure Revenue Expansion
11.3.3. Subscription and Usage-Based Robotics Models
11.3.4. ASC-Optimized Robotic Platforms
11.3.5. Implant-Robotics Ecosystem Bundling
11.3.6. Multi-Robot Health System Standardization

11.4. Robotic Procedure Penetration Outlook
11.5. U.S. Installed Base Outlook
11.6. System Replacement and Upgrade Cycle Outlook
11.7. Business Opportunities for Startups and Existing Players
11.8. Investment Prioritization Matrix
11.9. Technology Commercialization Readiness Matrix
11.10. Long-Term Competitive Disruption Analysis

What this section provides: This section prepares clients for future shifts in robotic technology, automation, AI, business models, procedure penetration, installed-base expansion, system replacement, and competitive structure through 2035.

12. U.S. Medical Robotics and Navigation Systems Market: Strategic Recommendations

12.1. Recommendations for Medical Robotics Manufacturers
12.2. Recommendations for Surgical Navigation Companies
12.3. Recommendations for Hospitals and Integrated Health Systems
12.4. Recommendations for Ambulatory Surgery Centers
12.5. Recommendations for Orthopedic and Surgical Device Companies
12.6. Recommendations for Investors and Private Equity Firms
12.7. Recommendations for Distributors and Channel Partners
12.8. Recommendations for New Entrants and Startups
12.9. U.S. Go-to-Market Strategy Considerations
12.10. Product Positioning and Portfolio Expansion Guidance
12.11. Installed Base Expansion Strategy
12.12. Surgeon Conversion and Training Strategy
12.13. Hospital ROI and Economic Evidence Strategy
12.14. ASC Market Entry Strategy
12.15. Software, AI and Recurring Revenue Strategy
12.16. Partnership, Acquisition and Licensing Opportunities

What this section provides: This section converts market intelligence into actionable recommendations for product development, commercialization, hospital contracting, surgeon conversion, ASC penetration, portfolio expansion, investment, and competitive differentiation.

13. U.S. Medical Robotics and Navigation Systems Market: Disclaimer

13.1. Scope Limitation
13.2. Data Use Limitation
13.3. Market Sizing Limitation
13.4. Forecasting Limitation
13.5. Installed Base and Procedure Estimate Limitation
13.6. Company Revenue Allocation Limitation
13.7. Legal Disclaimer
13.8. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s analytical boundaries, data-use conditions, market-sizing methodology limitations, forecasting assumptions, company revenue allocation considerations, and legal limitations.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Medical Robotics and Navigation Systems Market: Market Definition and Scope
TABLE 3: U.S. Medical Robotics and Navigation Systems Market: Research Methodology Framework
TABLE 4: U.S. Medical Robotics and Navigation Systems Market: Key Assumptions
TABLE 5: U.S. Medical Robotics and Navigation Systems Market: Market Ecosystem Overview
TABLE 6: U.S. Medical Robotics and Navigation Systems Market: Market Boundary and Revenue Inclusion Framework
TABLE 7: U.S. Medical Robotics and Navigation Systems Market: Stakeholder Analysis
TABLE 8: U.S. Medical Robotics and Navigation Systems Market: Executive Summary Snapshot, 2025
TABLE 9: U.S. Medical Robotics and Navigation Systems Market: Analyst Viewpoint Summary
TABLE 10: U.S. Medical Robotics and Navigation Systems Market: Market Attractiveness Index
TABLE 11: U.S. Medical Robotics and Navigation Systems Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 12: U.S. Medical Robotics and Navigation Systems Market: Base Year Market Positioning, 2025
TABLE 13: U.S. Medical Robotics and Navigation Systems Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 14: U.S. Medical Robotics and Navigation Systems Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 15: U.S. Medical Robotics and Navigation Systems Market: Installed Base and Procedure Utilization Snapshot
TABLE 16: U.S. Medical Robotics and Navigation Systems Market: Capital Equipment vs. Recurring Revenue Analysis
TABLE 17: U.S. Medical Robotics and Navigation Systems Market: Drivers; Impact Analysis
TABLE 18: U.S. Medical Robotics and Navigation Systems Market: Restraints; Impact Analysis
TABLE 19: U.S. Medical Robotics and Navigation Systems Market: Opportunities; Impact Analysis
TABLE 20: U.S. Medical Robotics and Navigation Systems Market: Challenges; Impact Analysis
TABLE 21: U.S. Medical Robotics and Navigation Systems Market: Patent & Innovation Analysis, 2021–2025
TABLE 22: U.S. Medical Robotics and Navigation Systems Market: Medical Robotics Innovation Cycle Analysis
TABLE 23: U.S. Medical Robotics and Navigation Systems Market: Clinical Workflow Economics Matrix
TABLE 24: U.S. Medical Robotics and Navigation Systems Market: Cost per Procedure and Utilization Economics
TABLE 25: U.S. Medical Robotics and Navigation Systems Market: Hospital Capital Procurement Behavior Matrix
TABLE 26: U.S. Medical Robotics and Navigation Systems Market: Surgeon Adoption and Platform Preference Analysis
TABLE 27: U.S. Medical Robotics and Navigation Systems Market: ASC Adoption Readiness Analysis
TABLE 28: U.S. Medical Robotics and Navigation Systems Market: PESTEL Analysis
TABLE 29: U.S. Medical Robotics and Navigation Systems Market: Porter’s Five Forces Analysis
TABLE 30: U.S. Medical Robotics and Navigation Systems Market: Robotic System Pricing Trend Analysis, 2025–2035
TABLE 31: U.S. Medical Robotics and Navigation Systems Market: Instruments, Accessories and Consumables Pricing Analysis
TABLE 32: U.S. Medical Robotics and Navigation Systems Market: Service and Maintenance Contract Economics
TABLE 33: U.S. Medical Robotics and Navigation Systems Market: Value Chain Analysis
TABLE 34: U.S. Medical Robotics and Navigation Systems Market: Supply Chain Analysis
TABLE 35: U.S. Medical Robotics and Navigation Systems Market: Medical Robotics Component Ecosystem
TABLE 36: U.S. Medical Robotics and Navigation Systems Market: Application & Innovation Landscape
TABLE 37: U.S. Medical Robotics and Navigation Systems Market: FDA Regulatory Framework Analysis
TABLE 38: U.S. Medical Robotics and Navigation Systems Market: CMS Reimbursement and Coverage Landscape
TABLE 39: U.S. Medical Robotics and Navigation Systems Market: Hospital Capital Budget and ROI Framework
TABLE 40: U.S. Medical Robotics and Navigation Systems Market: Group Purchasing and Enterprise Contracting Dynamics
TABLE 41: U.S. Medical Robotics and Navigation Systems Market: Digital Surgery and Connected Operating Room Impact
TABLE 42: U.S. Medical Robotics and Navigation Systems Market: AI and Surgical Data Governance
TABLE 43: U.S. Medical Robotics and Navigation Systems Market: Cybersecurity Requirements for Connected Robotic Systems
TABLE 44: U.S. Medical Robotics and Navigation Systems Market: Import/Export Restrictions & Tariff Impact
TABLE 45: U.S. Medical Robotics and Navigation Systems Market: U.S. Manufacturing and Supply Chain Localization
TABLE 46: U.S. Medical Robotics and Navigation Systems Market: Impact of Escalating Geopolitical Tensions
TABLE 47: U.S. Medical Robotics and Navigation Systems Market: Hospital Value Analysis Committee Decision Framework
TABLE 48: U.S. Medical Robotics and Navigation Systems Market: Product & System Type Snapshot, 2025
TABLE 49: Segment Dashboard; Definition and Scope, by Product & System Type
TABLE 50: U.S. Medical Robotics and Navigation Systems Market, by Product & System Type, 2021–2035 (US$ Billion)
TABLE 51: U.S. Medical Robotics and Navigation Systems Market: Segment Share Analysis, by Product & System Type, 2025 & 2035 (%)
TABLE 52: Soft-Tissue Robotic Surgical Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: Orthopedic Robotic Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: Surgical Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: Robotic Endoluminal and Endoscopic Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: Robotic Radiosurgery and Specialty Interventional Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Medical Robotics and Navigation Systems Market: Application Snapshot, 2025
TABLE 58: Segment Dashboard; Definition and Scope, by Application
TABLE 59: U.S. Medical Robotics and Navigation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 60: U.S. Medical Robotics and Navigation Systems Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 61: General and Gastrointestinal Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: Urology and Gynecology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: Orthopedic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: Spine and Neurosurgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: Thoracic, Pulmonary, Cardiovascular, Radiosurgery and Other Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Medical Robotics and Navigation Systems Market: Technology Snapshot, 2025
TABLE 67: Segment Dashboard; Definition and Scope, by Technology
TABLE 68: U.S. Medical Robotics and Navigation Systems Market, by Technology, 2021–2035 (US$ Billion)
TABLE 69: U.S. Medical Robotics and Navigation Systems Market: Segment Share Analysis, by Technology, 2025 & 2035 (%)
TABLE 70: Teleoperated Multi-Arm Robotic Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: Robotic-Arm and Handheld Execution Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: Optical and Electromagnetic Navigation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: Image-Integrated Robotic Navigation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: AI-Enabled and Semi-Autonomous Guidance Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Medical Robotics and Navigation Systems Market: End User Snapshot, 2025
TABLE 76: Segment Dashboard; Definition and Scope, by End User
TABLE 77: U.S. Medical Robotics and Navigation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 78: U.S. Medical Robotics and Navigation Systems Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 79: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: Academic Medical Centers and Teaching Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: Orthopedic, Spine and Specialty Surgical Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: Cancer Centers and Specialized Interventional Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Medical Robotics and Navigation Systems Market: Regional Snapshot, 2025
TABLE 85: Segment Dashboard; Definition and Scope, by Geography
TABLE 86: U.S. Medical Robotics and Navigation Systems Market, by Geography, 2021–2035 (US$ Billion)
TABLE 87: U.S. Medical Robotics and Navigation Systems Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 88: U.S. Medical Robotics and Navigation Systems Market: Regional Installed Base and Procedure Utilization Analysis
TABLE 89: West Region U.S. Medical Robotics and Navigation Systems Market: Regional Overview and Trends
TABLE 90: West Region U.S. Medical Robotics and Navigation Systems Market: Key Manufacturers and Procurement Ecosystem
TABLE 91: West Region U.S. Medical Robotics and Navigation Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 92: West Region U.S. Medical Robotics and Navigation Systems Market, by Product & System Type, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Medical Robotics and Navigation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Medical Robotics and Navigation Systems Market, by Technology, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Medical Robotics and Navigation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 96: California Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Washington Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Arizona Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Colorado Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Oregon Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Utah Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Nevada Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: New Mexico Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Idaho Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Montana Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Wyoming Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Alaska Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Hawaii Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Northeast Region U.S. Medical Robotics and Navigation Systems Market: Regional Overview and Trends
TABLE 110: Northeast Region U.S. Medical Robotics and Navigation Systems Market: Key Manufacturers and Procurement Ecosystem
TABLE 111: Northeast Region U.S. Medical Robotics and Navigation Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 112: Northeast Region U.S. Medical Robotics and Navigation Systems Market, by Product & System Type, 2021–2035 (US$ Billion)
TABLE 113: Northeast Region U.S. Medical Robotics and Navigation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 114: Northeast Region U.S. Medical Robotics and Navigation Systems Market, by Technology, 2021–2035 (US$ Billion)
TABLE 115: Northeast Region U.S. Medical Robotics and Navigation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 116: New York Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Massachusetts Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: New Jersey Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Pennsylvania Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: Connecticut Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: Maine Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: Vermont Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: New Hampshire Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Rhode Island Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Delaware Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: South Region U.S. Medical Robotics and Navigation Systems Market: Regional Overview and Trends
TABLE 127: South Region U.S. Medical Robotics and Navigation Systems Market: Key Manufacturers and Procurement Ecosystem
TABLE 128: South Region U.S. Medical Robotics and Navigation Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 129: South Region U.S. Medical Robotics and Navigation Systems Market, by Product & System Type, 2021–2035 (US$ Billion)
TABLE 130: South Region U.S. Medical Robotics and Navigation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 131: South Region U.S. Medical Robotics and Navigation Systems Market, by Technology, 2021–2035 (US$ Billion)
TABLE 132: South Region U.S. Medical Robotics and Navigation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 133: Texas Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: Florida Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Georgia Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: North Carolina Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Tennessee Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: South Carolina Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Alabama Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Mississippi Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Louisiana Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Arkansas Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Kentucky Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Oklahoma Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Virginia Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Maryland Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: West Virginia Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Midwest Region U.S. Medical Robotics and Navigation Systems Market: Regional Overview and Trends
TABLE 149: Midwest Region U.S. Medical Robotics and Navigation Systems Market: Key Manufacturers and Procurement Ecosystem
TABLE 150: Midwest Region U.S. Medical Robotics and Navigation Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 151: Midwest Region U.S. Medical Robotics and Navigation Systems Market, by Product & System Type, 2021–2035 (US$ Billion)
TABLE 152: Midwest Region U.S. Medical Robotics and Navigation Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 153: Midwest Region U.S. Medical Robotics and Navigation Systems Market, by Technology, 2021–2035 (US$ Billion)
TABLE 154: Midwest Region U.S. Medical Robotics and Navigation Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 155: Illinois Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: Ohio Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: Michigan Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 158: Minnesota Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 159: Indiana Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 160: Wisconsin Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 161: Missouri Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: Iowa Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: Kansas Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Nebraska Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: North Dakota Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: South Dakota Medical Robotics and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: U.S. Medical Robotics and Navigation Systems Market: Competitive Landscape Snapshot, 2025
TABLE 168: U.S. Medical Robotics and Navigation Systems Market: Key Company Market Share Analysis, 2025
TABLE 169: U.S. Medical Robotics and Navigation Systems Market: Company Positioning Matrix
TABLE 170: U.S. Medical Robotics and Navigation Systems Market: Product and Platform Portfolio Benchmarking
TABLE 171: U.S. Medical Robotics and Navigation Systems Market: Competitive Strategy Benchmarking
TABLE 172: U.S. Medical Robotics and Navigation Systems Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 173: Intuitive Surgical: Company Profile
TABLE 174: Stryker: Company Profile
TABLE 175: Medtronic: Company Profile
TABLE 176: Zimmer Biomet: Company Profile
TABLE 177: Johnson & Johnson MedTech: Company Profile
TABLE 178: Globus Medical: Company Profile
TABLE 179: Smith+Nephew: Company Profile
TABLE 180: Brainlab: Company Profile
TABLE 181: Siemens Healthineers: Company Profile
TABLE 182: GE HealthCare: Company Profile
TABLE 183: Philips: Company Profile
TABLE 184: Accuray: Company Profile
TABLE 185: Stereotaxis: Company Profile
TABLE 186: PROCEPT BioRobotics: Company Profile
TABLE 187: THINK Surgical: Company Profile
TABLE 188: Alphatec Holdings: Company Profile
TABLE 189: Augmedics: Company Profile
TABLE 190: KARL STORZ: Company Profile
TABLE 191: Moon Surgical: Company Profile
TABLE 192: Renishaw: Company Profile
TABLE 193: OrthAlign: Company Profile
TABLE 194: CMR Surgical: Company Profile
TABLE 195: Vicarious Surgical: Company Profile
TABLE 196: Elekta: Company Profile
TABLE 197: Microbot Medical: Company Profile
TABLE 198: U.S. Medical Robotics and Navigation Systems Market: Future Market Scenario Analysis, 2026–2035
TABLE 199: U.S. Medical Robotics and Navigation Systems Market: Disruptive Technologies Impact Matrix
TABLE 200: U.S. Medical Robotics and Navigation Systems Market: Robotic Procedure Penetration Outlook
TABLE 201: U.S. Medical Robotics and Navigation Systems Market: Installed Base Outlook, 2026–2035
TABLE 202: U.S. Medical Robotics and Navigation Systems Market: System Replacement and Upgrade Cycle Outlook
TABLE 203: U.S. Medical Robotics and Navigation Systems Market: Emerging Business Trends
TABLE 204: U.S. Medical Robotics and Navigation Systems Market: Business Opportunities for Startups and Existing Players
TABLE 205: U.S. Medical Robotics and Navigation Systems Market: Investment Prioritization Matrix
TABLE 206: U.S. Medical Robotics and Navigation Systems Market: Technology Commercialization Readiness Matrix
TABLE 207: U.S. Medical Robotics and Navigation Systems Market: Strategic Recommendations for Medical Robotics Manufacturers
TABLE 208: U.S. Medical Robotics and Navigation Systems Market: Strategic Recommendations for Surgical Navigation Companies
TABLE 209: U.S. Medical Robotics and Navigation Systems Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 210: U.S. Medical Robotics and Navigation Systems Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 211: U.S. Medical Robotics and Navigation Systems Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 212: U.S. Medical Robotics and Navigation Systems Market: Strategic Recommendations for New Entrants and Startups
TABLE 213: U.S. Medical Robotics and Navigation Systems Market: U.S. Go-to-Market Strategy Considerations
TABLE 214: U.S. Medical Robotics and Navigation Systems Market: Installed Base Expansion and Surgeon Conversion Strategy
TABLE 215: U.S. Medical Robotics and Navigation Systems Market: Hospital ROI and Economic Evidence Strategy
TABLE 216: U.S. Medical Robotics and Navigation Systems Market: Software, AI and Recurring Revenue Strategy
TABLE 217: U.S. Medical Robotics and Navigation Systems Market: Scope Limitation
TABLE 218: U.S. Medical Robotics and Navigation Systems Market: Data Use Limitation
TABLE 219: U.S. Medical Robotics and Navigation Systems Market: Market Sizing Limitation
TABLE 220: U.S. Medical Robotics and Navigation Systems Market: Forecasting Limitation
TABLE 221: U.S. Medical Robotics and Navigation Systems Market: Installed Base and Procedure Estimate Limitation
TABLE 222: U.S. Medical Robotics and Navigation Systems Market: Company Revenue Allocation Limitation
TABLE 223: U.S. Medical Robotics and Navigation Systems Market: Legal Disclaimer
TABLE 224: U.S. Medical Robotics and Navigation Systems Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Medical Robotics and Navigation Systems Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Medical Robotics and Navigation Systems Market Ecosystem
FIGURE 4: Market Boundary and Revenue Inclusion Framework
FIGURE 5: Stakeholder Ecosystem
FIGURE 6: U.S. Medical Robotics and Navigation Systems Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 7: U.S. Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 8: U.S. Medical Robotics and Navigation Systems Market Year-wise Growth Curve, 2021–2035
FIGURE 9: Installed Base and Procedure Utilization Framework
FIGURE 10: Capital Equipment vs. Recurring Revenue Model
FIGURE 11: Market Attractiveness Analysis
FIGURE 12: Market Dynamics
FIGURE 13: Innovation & Patent Landscape, 2021–2025
FIGURE 14: Medical Robotics Innovation Cycle
FIGURE 15: Clinical Workflow Economics Framework
FIGURE 16: Cost per Procedure and Utilization Economics Framework
FIGURE 17: Hospital Capital Procurement Decision Framework
FIGURE 18: Surgeon Adoption and Platform Preference Matrix
FIGURE 19: ASC Robotics Adoption Readiness Framework
FIGURE 20: PESTEL Analysis
FIGURE 21: Porter’s Five Forces Analysis
FIGURE 22: Value Chain Analysis
FIGURE 23: Supply Chain Analysis
FIGURE 24: Medical Robotics Component Ecosystem
FIGURE 25: FDA Regulatory Pathway Framework for Medical Robotics and Navigation Systems
FIGURE 26: CMS Reimbursement and Coverage Landscape
FIGURE 27: Hospital Capital Budget and Robotics ROI Framework
FIGURE 28: Digital Surgery and Connected Operating Room Ecosystem
FIGURE 29: AI-Enabled Surgical Data and Workflow Architecture
FIGURE 30: Product & System Type Segment Market Share Analysis, 2025 & 2035
FIGURE 31: Product & System Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Soft-Tissue Robotic Surgical Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Orthopedic Robotic Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Surgical Navigation Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Robotic Endoluminal and Endoscopic Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Robotic Radiosurgery and Specialty Interventional Robotics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 38: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: General and Gastrointestinal Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Urology and Gynecology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Orthopedic Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Spine and Neurosurgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Thoracic, Pulmonary, Cardiovascular, Radiosurgery and Other Applications Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Technology Segment Market Share Analysis, 2025 & 2035
FIGURE 45: Technology Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Teleoperated Multi-Arm Robotic Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Robotic-Arm and Handheld Execution Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Optical and Electromagnetic Navigation Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Image-Integrated Robotic Navigation Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: AI-Enabled and Semi-Autonomous Guidance Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 52: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Academic Medical Centers and Teaching Hospitals Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Orthopedic, Spine and Specialty Surgical Hospitals Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Cancer Centers and Specialized Interventional Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 59: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: U.S. Robotics Installed Base and Procedure Utilization by Region, 2025
FIGURE 61: West Region Market Share Analysis by State, 2025
FIGURE 62: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: California Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Washington Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Arizona Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Colorado Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Oregon Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Utah Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Nevada Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: New Mexico Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Idaho Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Montana Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Wyoming Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Alaska Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Hawaii Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Northeast Region Market Share Analysis by State, 2025
FIGURE 77: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New York Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Massachusetts Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: New Jersey Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Pennsylvania Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Connecticut Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Maine Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Vermont Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: New Hampshire Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Rhode Island Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Delaware Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: South Region Market Share Analysis by State, 2025
FIGURE 89: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Texas Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Florida Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Georgia Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: North Carolina Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Tennessee Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: South Carolina Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Alabama Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Mississippi Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Louisiana Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Arkansas Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Kentucky Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Oklahoma Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Virginia Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Maryland Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: West Virginia Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Midwest Region Market Share Analysis by State, 2025
FIGURE 106: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Illinois Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Ohio Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Michigan Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Minnesota Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Indiana Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Wisconsin Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Missouri Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Iowa Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Kansas Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Nebraska Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: North Dakota Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: South Dakota Medical Robotics and Navigation Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 120: Company Positioning Matrix
FIGURE 121: Key Player Product and Platform Portfolio Benchmarking
FIGURE 122: Competitive Strategy Benchmarking
FIGURE 123: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 124: Medical Robotics and Navigation Innovation Roadmap
FIGURE 125: Soft-Tissue Robotic Surgery Competitive Evolution
FIGURE 126: Orthopedic Robotics Adoption Roadmap
FIGURE 127: Surgical Navigation and Robotic Integration Roadmap
FIGURE 128: AI-Enabled and Semi-Autonomous Surgery Opportunity Map
FIGURE 129: Robotic Procedure Penetration Outlook, 2026–2035
FIGURE 130: U.S. Medical Robotics Installed Base Outlook, 2026–2035
FIGURE 131: Robotic System Replacement and Upgrade Cycle
FIGURE 132: Future Market Scenario Analysis, 2026–2035
FIGURE 133: Disruptive Technologies Impact Matrix
FIGURE 134: Emerging Business Trends Matrix
FIGURE 135: Technology Commercialization Readiness Matrix
FIGURE 136: Investment Prioritization Matrix
FIGURE 137: Strategic Growth Roadmap for U.S. Medical Robotics and Navigation Companies
FIGURE 138: Hospital and Health System Robotics Adoption Strategy Framework
FIGURE 139: ASC Robotics Market Entry Framework
FIGURE 140: U.S. Go-to-Market Strategy Framework
FIGURE 141: Installed Base Expansion and Surgeon Conversion Framework
FIGURE 142: Hospital ROI and Economic Evidence Framework
FIGURE 143: Software, AI and Recurring Revenue Growth Framework
FIGURE 144: Report Scope and Disclaimer Framework